MENU
AVXL
AS OF
Dec 12 closing price
Price
$4.02
Change
-$0.09 (-2.19%)
Capitalization
359.18M
54 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AVXL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Anavex Life Sciences (AVXL) Ownership - Who owns Anavex Life Sciences?

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
359.18M
P/E Ratio
N/A
Total Cash
102.58M
Projected Growth
N/A
Total Debt
88.23K
Revenue
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
1.15
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

AVXL
Capitalization
359M
P/E Ratio
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
103M
Total Cash/Share
1.15
Total Debt
88.2K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
94.9M
P/B Ratio
3.79
Cash Flow
N/A
Earnings
-0.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
87K
Current Ratio
11.60
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-46.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-38.75
Shares Held By Institutions
496M
Shares Outstanding - Current
89.3M
Total Liabilities
8.95M
Total Volume MTD
N/A
Value
1
Gain YTD
-61.732
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AVXL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVXL showed earnings on November 25, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AVXL
A.I. Advisor
published General Information

General Information

a developer of innovative drug compounds

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com